A preliminary clinical study by our group demonstrated Bushen Yisui Capsule （formerly called Er- huang Formula） in combination with conventional therapy is an effective prescription for the treat- ment of multiple s...A preliminary clinical study by our group demonstrated Bushen Yisui Capsule （formerly called Er- huang Formula） in combination with conventional therapy is an effective prescription for the treat- ment of multiple sclerosis. However, its effect on axonal injury during early multiple sclerosis re- mains unclear. In this study, a MOG35 55-immunized C57BL/6 mouse model of experimental auto- immune encephalomyelitis was intragastrically administered Bushen Yisui Capsule. The results showed that Bushen Yisui Capsule effectively improved clinical symptoms and neurological function of experimental autoimmune encephalomyelitis. In addition, amyloid precursor protein expression was down-regulated and microtubule-associated protein 2 was up-regulated. Experimental findings indicate that the disease-preventive mechanism of Bushen Yisui Capsule in experimental autoim- mune encephalomyelitis was mediated by amelioration of axonal damage and promotion of regen- eration. But the effects of the high-dose Bushen Yisui Capsule group was not better than that of the medium-dose and low-dose Bushen Yisui Capsule group in preventing neurological dysfunction.展开更多
基金supported by the National Natural Science Foundation of China,No.81072765,81173237,81273742Scientific Research Key Project of Beijing Municipal Commission of Education,No.KZ201310025023Special Fund for Capital Traditional Chinese Medicine and Nursing Research,No.12ZYH01
文摘A preliminary clinical study by our group demonstrated Bushen Yisui Capsule （formerly called Er- huang Formula） in combination with conventional therapy is an effective prescription for the treat- ment of multiple sclerosis. However, its effect on axonal injury during early multiple sclerosis re- mains unclear. In this study, a MOG35 55-immunized C57BL/6 mouse model of experimental auto- immune encephalomyelitis was intragastrically administered Bushen Yisui Capsule. The results showed that Bushen Yisui Capsule effectively improved clinical symptoms and neurological function of experimental autoimmune encephalomyelitis. In addition, amyloid precursor protein expression was down-regulated and microtubule-associated protein 2 was up-regulated. Experimental findings indicate that the disease-preventive mechanism of Bushen Yisui Capsule in experimental autoim- mune encephalomyelitis was mediated by amelioration of axonal damage and promotion of regen- eration. But the effects of the high-dose Bushen Yisui Capsule group was not better than that of the medium-dose and low-dose Bushen Yisui Capsule group in preventing neurological dysfunction.
